NASDAQ:PDEX Pro-Dex Q3 2026 Earnings Results & Report $69.33 -2.16 (-3.02%) As of 02:50 PM Eastern This is a fair market value price provided by Massive. Learn more. Pro-Dex beat analyst expectations on both earnings and revenue in its Q3 2026 results, released April 30, 2026. The company reported EPS of $1.20 versus the $0.62 consensus estimate, while revenue of $19.95 million topped the $17.90 million estimate by $2.05 million. Research:ProfileEarnings HistoryForecast Earnings Announcement Details QuarterQ3 2026Report DateApril 30, 2026TimeBefore Market OpensConference Call7:00 AM ET Pro-Dex EPS ResultsActual EPS$1.20Consensus EPS $0.62Beat/MissBeat by +$0.58One Year Ago EPSN/AEPS Beat Rate7 of last 8 quartersPro-Dex Revenue ResultsActual Revenue$19.95 millionExpected Revenue$17.90 millionBeat/MissBeat by +$2.05 millionYoY Revenue GrowthN/AConference Call ResourcesPress Release (8-K)Quarterly Report (10-Q)Earnings HistoryCompany ProfilePowered by Earnings DocumentsPress Release(8-K)Quarterly report(10-Q) Pro-Dex Q3 2026 Earnings FAQ Did Pro-Dex beat earnings estimates for Q3 2026? Pro-Dex (NASDAQ:PDEX) reported earnings of $1.20 per share for Q3 2026, beating the consensus estimate of $0.62. The report was announced on Thursday, April 30, 2026. What was Pro-Dex's revenue for Q3 2026? Pro-Dex reported revenue of $19.95 million for Q3 2026, against a consensus estimate of $17.90 million. Pro-Dex Earnings HeadlinesPro-Dex, Inc. reports fiscal 2027 first quarter resultsOctober 29, 2026 | msn.comPro-Dex, Inc. Reports Earnings Results for the First Quarter Ended September 30, 2026October 29, 2026 | marketscreener.comMMany investors are about to lose everythingTwenty five years ago, this analyst predicted the fiber optic boom and called Amazon before it became a household name. Now he says a similar shift is unfolding in AI infrastructure. Hundreds of billions are pouring into AI data centers, but he warns the builders could get crushed by their own costs while one overlooked sector absorbs the spending.November 12 at 1:00 AM | Porter & Company (Ad)5 Biotech And Medical Device Stocks In Focus: Pro-Dex, Modular Medical, ENvue Medical & MoreSeptember 4, 2026 | rttnews.comPro-Dex Jumps On Higher Q4 Earnings And Revenue GrowthSeptember 4, 2026 | rttnews.comPro-Dex Inc (PDEX) Positioned to Strengthen with Zimmer’s mBos Robot CommercializationAugust 10, 2026 | insidermonkey.comSee More Pro-Dex Headlines Get Earnings Announcements in your inboxWant to stay updated on the latest earnings announcements and upcoming reports for companies like Pro-Dex? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Pro-Dex and other key companies, straight to your email. Email Address About Pro-DexPro-Dex (NASDAQ:PDEX) (NASDAQ:PDEX) designs, develops and manufactures powered surgical instruments and related products for the medical device industry. The company primarily serves original equipment manufacturers that incorporate Pro-Dex instruments into surgical systems sold under their own brands. Its products include battery-powered and pneumatic handpieces, rotary instruments, micro-drills, saws, controllers and other specialized equipment used in orthopedic, dental, ophthalmic and other surgical applications. Pro-Dex also provides engineering, product development, manufacturing and related support services tailored to customer specifications. Founded in 1978 and headquartered in Irvine, California, Pro-Dex serves medical device customers in the United States and international markets. Its business is focused on long-term relationships with medical technology companies that require specialized instrument design and production capabilities.View Pro-Dex ProfileRead more More Earnings Resources from MarketBeat Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Latest Articles Hims & Hers Bounced Back 9%, But Its Earnings Reveal a Costly Trade-OffSix Flags Lost $366 Million in Q3—Its Insiders Just Went Shopping3 Pharmaceutical Stocks That Offer Safety and GrowthKeeping AI Cool: AAON Rides the AI Heatwave to Record GrowthPalantir’s Real Washington Risk Isn’t the Budget—It’s OversightCoreWeave's Backlog Is Surging—Can the Stock Follow?Can Constellation Energy's Contracts Power a Stock Rebound? Upcoming Earnings Mizuho Financial Group (11/13/2026)Mitsubishi UFJ Financial Group (11/13/2026)Sumitomo Mitsui Financial Group (11/13/2026)Home Depot (11/17/2026)Walt Disney (11/17/2026)NVIDIA (11/17/2026)Lowe's Companies (11/18/2026)PDD (11/18/2026)TJX Companies (11/18/2026)Target (11/18/2026) Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
